As an essential anti-angiogenic agent, endostar exerts anti-tumor angiogenic effects by blocking vascular endothelial growth factor (VEGF)-induced endothelial cell KDR/Flk-1 tyrosine phosphorylation [12]. Here, VEGFA is linked to neoplasm.